by cooper-dsi | 2023 October | PRESS RELEASE
2nd October 2023 Cooper Consumer Health (“Cooper CH”) a leading European independent over-the-counter drug manufacturer and distributor, is pleased to announce today that it has submitted an offer to Viatris Inc. (“Viatris”, NASDAQ:VTRS), a global healthcare company,...
by cooper-dsi | 2023 April | PRESS RELEASE
Factors undermining men’s erectile health include lifestyle-related chronic conditions,social pressures and changing sexual norms [Paris, April 18th] – Globally, 1 in 5 men aged 18 and over struggle with erectile problems – impacting theirquality of life, as...
by cooper-dsi | 2021 November | PRESS RELEASE
8 November 2021 The acquisition of Cooper Consumer Health by CVC Capital Partners Fund VII (“CVC”) is completed Cooper Consumer Health (“Cooper”) a leading European independent over-the-counter drug manufacturer and distributor, is pleased to announce the appointment...
by Anfetamine | 2020 November | PRESS RELEASE
Cooper Consumer Health has signed an exclusive negotiation agreement to acquire 100% of the shares of Laboratoire Tradiphar, a French-based laboratory that notably manufactures and distributes the M.O.Cochon ointment, an iconic brand with a strong heritage in France....
by Anfetamine | 2019 November | PRESS RELEASE
COOPER Consumer Health (ex Alpha HealthGroup), through its subsidiary Vemedia, has completed the acquisition of the brand Zeninas from Puerto Galiano. “The brand was launched in 1958 and has a strong brand equity amongst consumers. We want to perpetuate this history...
by Anfetamine | 2019 November | PRESS RELEASE
COOPER Consumer Health (ex Alpha HealthGroup), through its subsidiary Vemedia, has signed with GSK an exclusive negotiation agreement to acquire a portfolio of two Italian brands from GSK: Bialcol and Cibalgina. With this acquisition, COOPER Consumer Health (ex Alpha...
